RENOCRIT 4000 IU INJECTION

Renocrit 4000IU injection contains active components like Recombinant human erythropoietin Alfa/Ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The drug treats anemia that is caused by chronic kidney illness (CKD), chemotherapy for cancer, or HIV treatment using zidovudine. It also reduces the requirement for transfusions of red blood cells for patients at risk of blood loss because of planned surgery and other surgical procedures.
Renocrit 4000IU injection should not be used by patients who have excessive hypersensitivity or one of the components thereof, as well as uncontrolled hypertension, active thrombotic microangiopathy (TMA) or Pure red cell cancer (PRCA), uncontrolled seizures as well as lactation or pregnancy. Also, it should be used carefully in patients who have a background of bleeding clots or heart disease, kidney disease, stroke thalassemia, liver diseases, sickle cell anemia and myelodysplastic disorder, cancer, or leukemia. It should not be used for children under 18 when the benefits outweigh the risks. Seniors using this medication should be watched closely for adverse consequences. Before you begin this treatment, it’s crucial to consult your physician about the potential dangers and benefits associated with Renocrit IV injection of 4000IU injection.